Immunosuppression in the Age of Precision Medicine

Semin Nephrol. 2022 Jan;42(1):86-98. doi: 10.1016/j.semnephrol.2022.01.001.

Author

Steven Gabardi¹

Affiliation

¹ Abdominal Organ Transplant Clinical Specialist, Department of Transplant Surgery, Brigham and Women's Hospital, Boston, MA. Electronic address: sgabardi@bwh.harvard.edu.

PMID: 35618398
DOI: 10.1016/j.semnephrol.2022.01.001

Abstract

The article focuses on immunosuppression pharmacology, adverse-event profile, clinical efficacy, and, when available, pharmacogenomic data.

Keywords: immunosuppression; pharmacogenetics; pharmacogenomics; pharmacology.

Copyright © 2022 Elsevier Inc. All rights reserved.

Publication types

Review

MeSH terms

Humans
Immunosuppression Therapy
Pharmacogenetics*
Precision Medicine*
Treatment Outcome